Approximately 1 in 250 women are carriers of the abnormal gene that causes Fragile X syndrome, a genetic condition that can lead to learning disabilities and early menopause. The Fragile X Society is urging GPs to test patients for this condition, highlighting the lack of awareness surrounding it.
Pete Richardson, managing director of Fragile X Society, emphasises the importance of understanding Fragile X syndrome, which affects approximately one in 4,000 males and one in 6,000 females. The condition can result in a range of challenges with learning, social interactions, language, attention, emotions, and behaviour.
Misconceptions exist around Fragile X syndrome, including the fact that it can present without a family history and affect both genders. The syndrome is caused by a mutation in the FMR1 gene on the X chromosome, usually inherited through women, though both males and females can be carriers.
Symptoms of Fragile X syndrome include intellectual disabilities, behavioural issues like impulsiveness and restlessness, and physical traits such as a long face and prominent ears. Women carriers are at risk of Fragile X-Associated Primary Ovarian Insufficiency, which can lead to fertility problems and early menopause.
Diagnosis of Fragile X syndrome is through a DNA test, which can be facilitated by GPs or genetic counsellors. While there is no cure, early intervention through education, therapy, and medications can help manage the symptoms and improve the individual’s quality of life.
Richardson stresses the importance of early intervention for children with Fragile X syndrome to maximise their potential and learning abilities. Understanding the signs and effects of Fragile X syndrome is crucial in providing support and care for individuals and families affected by this genetic condition.